Table 2.
Characteristics of MPs in healthy subjects and patients with AMI or CAD
| Characteristics | AMI | CAD | Healthy controls | P-value |
|---|---|---|---|---|
| CD31+/CD42b− MPs | 12.5 ± 5.7 | 0.08 ± 0.07 | 0.04 ± 0.03 | 0.0003* |
| CD31+/CD42b+ MPs | 3.4 ± 2.4 | 3.9 ± 1.8 | 3.8 ± 2.1 | 0.18 |
| CD31−/CD42b− MPS | 79 ± 8.9 | 82 ± 11.9 | 84 ± 10.6 | 0.37 |
Comparison was conducted between SCAD and AMI group and P-value was shown, * a value of P<0.05 was considered with significant difference.